サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1153347

世界の医薬品用造粒機市場：産業調査報告書、成長動向と競合分析 (2022年～2028年)

Global Granulator for Pharmaceutical Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
出版日: | 発行: QYResearch | ページ情報: 英文 108 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の医薬品用造粒機市場：産業調査報告書、成長動向と競合分析 (2022年～2028年)
出版日: 2022年11月16日
発行: QYResearch
ページ情報: 英文 108 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、医薬品用造粒機 (Granulator for Pharmaceutical) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 医薬品用造粒機 調査対象範囲
  • 市場 セグメントタイプ別
    • 世界の医薬品用造粒機の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Dry Granulator
    • Wet Granulator
  • 市場セグメント：用途別
    • 世界の医薬品用造粒機の市場規模成長率：用途別, 2017 VS 2021 VS 2028
    • Pharmaceutical Company
    • Other
  • 調査目的
  • 対象期間

第2章 世界の市場の生産

  • 世界の医薬品用造粒機の生産能力 (2017-2028)
  • 世界の医薬品用造粒機の生産：地域別: 2017 VS 2021 VS 2028
  • 世界の医薬品用造粒機の生産：地域別
    • 世界の医薬品用造粒機の生産実績：地域別 (2017-2022)
    • 世界の医薬品用造粒機の生産予測：地域別 (2023-2028)
    • 北米
    • 欧州
    • 日本
    • 中国
    • 韓国
    • インド
  • 市場動向
    • 医薬品用造粒機 業界動向
    • 医薬品用造粒機 市場の促進要因
    • 医薬品用造粒機 市場の課題
    • 医薬品用造粒機 市場の抑制要因

第3章 世界の医薬品用造粒機 売上

  • 世界の医薬品用造粒機の販売 推定および予測 2017-2028
  • 世界の医薬品用造粒機の収益 推定および予測 2017-2028
  • 世界の医薬品用造粒機の収益：地域別: 2017 VS 2021 VS 2028
  • 世界のトップ 医薬品用造粒機地域：売上別
    • 世界のトップ 医薬品用造粒機 地域：売上別 (2017年～2022年)
    • 世界のトップ 医薬品用造粒機地域：売上別 (2023-2028)
  • 世界のトップ 医薬品用造粒機の上位地域：収益別
    • 世界のトップ 医薬品用造粒機 地域：収益別（2017年～2022年）
    • 世界のトップ 医薬品用造粒機の上位地域：収益別 (2023-2028)
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ

第4章 競合：企業別

  • 世界の医薬品用造粒機の生産能力：企業別
  • 世界の医薬品用造粒機の販売：企業別
    • 世界のトップ 医薬品用造粒機の上位企業：販売別 (2017-2022)
    • 世界のトップ 医薬品用造粒機の上位企業市場シェア：販売別 (2017-2022)
    • 世界の上位10・上位5企業： 医薬品用造粒機 売上2021
  • 世界の医薬品用造粒機の収益：企業別
    • 世界のトップ 医薬品用造粒機の上位企業：収益別 (2017-2022)
    • 世界のトップ 医薬品用造粒機の上位企業市場シェア：収益別 (2017-2022)
    • 世界の上位10・上位5企業： 医薬品用造粒機の収益 2021
  • 世界の医薬品用造粒機の販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 ・ HHI)
    • 世界の医薬品用造粒機の市場シェア：企業タイプ別 (Tier 1, Tier 2, ・ Tier 3)
    • 世界の医薬品用造粒機 企業の地理的分布
  • M&A, 拡張計画

第5章 推定および予測 タイプ別

  • 世界の医薬品用造粒機の販売：タイプ別
    • 世界の医薬品用造粒機の販売実績：タイプ別 (2017-2022)
    • 世界の医薬品用造粒機の販売予測：タイプ別 (2023-2028)
    • 世界の医薬品用造粒機の販売市場シェア：タイプ別 (2017-2028)
  • 世界の医薬品用造粒機の収益：タイプ別
    • 世界の医薬品用造粒機の収益実績：タイプ別 (2017-2022)
    • 世界の医薬品用造粒機の収益予測：タイプ別 (2023-2028)
    • 世界の医薬品用造粒機の収益市場シェア：タイプ別 (2017-2028)
  • 世界の医薬品用造粒機の価格：タイプ別
    • 世界の医薬品用造粒機の価格：タイプ別 (2017-2022)
    • 世界の医薬品用造粒機の価格予測：タイプ別 (2023-2028)

第6章 市場規模：用途別

  • 世界の医薬品用造粒機の販売：用途別
    • 世界の医薬品用造粒機の販売実績：用途別 (2017-2022)
    • 世界の医薬品用造粒機の販売予測：用途別 (2023-2028)
    • 世界の医薬品用造粒機の販売市場シェア：用途別 (2017-2028)
  • 世界の医薬品用造粒機の収益：用途別
    • 世界の医薬品用造粒機の収益実績：用途別 (2017-2022)
    • 世界の医薬品用造粒機の収益予測：用途別 (2023-2028)
    • 世界の医薬品用造粒機の収益市場シェア：用途別 (2017-2028)
  • 世界の医薬品用造粒機の価格：用途別
    • 世界の医薬品用造粒機の価格：用途別 (2017-2022)
    • 世界の医薬品用造粒機の価格予測：用途別 (2023-2028)

第7章 北米

  • 北米の医薬品用造粒機 売上内訳：企業別
    • 北米の医薬品用造粒機 売上：企業別 (2017-2022)
    • 北米の医薬品用造粒機 収益：企業別 (2017-2022)
  • 北米の医薬品用造粒機 市場規模：タイプ別
    • 北米の医薬品用造粒機の販売：タイプ別 (2017-2028)
    • 北米の医薬品用造粒機の収益：タイプ別 (2017-2028)
  • 北米の医薬品用造粒機 市場規模：用途別
    • 北米の医薬品用造粒機の販売：用途別 (2017-2028)
    • 北米の医薬品用造粒機の収益：用途別 (2017-2028)
  • 北米の医薬品用造粒機 市場規模：国別
    • 北米の医薬品用造粒機の販売：国別 (2017-2028)
    • 北米の医薬品用造粒機の収益：国別 (2017-2028)
    • 米国
    • カナダ

第8章 欧州

  • 欧州の医薬品用造粒機 売上内訳：企業別
    • 欧州の医薬品用造粒機 売上：企業別 (2017-2022)
    • 欧州の医薬品用造粒機 収益：企業別 (2017-2022)
  • 欧州の医薬品用造粒機 市場規模：タイプ別
    • 欧州の医薬品用造粒機の販売：タイプ別 (2017-2028)
    • 欧州の医薬品用造粒機の収益：タイプ別 (2017-2028)
  • 欧州の医薬品用造粒機 市場規模：用途別
    • 欧州の医薬品用造粒機の販売：用途別 (2017-2028)
    • 欧州の医薬品用造粒機の収益：用途別 (2017-2028)
  • 欧州の医薬品用造粒機 市場規模：国別
    • 欧州の医薬品用造粒機の販売：国別 (2017-2028)
    • 欧州の医薬品用造粒機の収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第9章 アジア太平洋

  • アジア太平洋の医薬品用造粒機 売上内訳：企業別
    • アジア太平洋の医薬品用造粒機 売上：企業別 (2017-2022)
    • アジア太平洋の医薬品用造粒機 収益：企業別 (2017-2022)
  • アジア太平洋の医薬品用造粒機 市場規模：タイプ別
    • アジア太平洋の医薬品用造粒機の販売：タイプ別 (2017-2028)
    • アジア太平洋の医薬品用造粒機の収益：タイプ別 (2017-2028)
  • アジア太平洋の医薬品用造粒機 市場規模：用途別
    • アジア太平洋の医薬品用造粒機の販売：用途別 (2017-2028)
    • アジア太平洋の医薬品用造粒機の収益：用途別 (2017-2028)
  • アジア太平洋の医薬品用造粒機 市場規模：地域別
    • アジア太平洋の医薬品用造粒機の販売：地域別 (2017-2028)
    • アジア太平洋の医薬品用造粒機の収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン

第10章 ラテンアメリカ

  • ラテンアメリカの医薬品用造粒機 売上内訳：企業別
    • ラテンアメリカの医薬品用造粒機 売上：企業別 (2017-2022)
    • ラテンアメリカの医薬品用造粒機 収益：企業別 (2017-2022)
  • ラテンアメリカの医薬品用造粒機 市場規模：タイプ別
    • ラテンアメリカの医薬品用造粒機の販売：タイプ別 (2017-2028)
    • ラテンアメリカの医薬品用造粒機の収益：タイプ別 (2017-2028)
  • ラテンアメリカの医薬品用造粒機 市場規模：用途別
    • ラテンアメリカの医薬品用造粒機の販売：用途別 (2017-2028)
    • ラテンアメリカの医薬品用造粒機の収益：用途別 (2017-2028)
  • ラテンアメリカの医薬品用造粒機 市場規模：国別
    • ラテンアメリカの医薬品用造粒機の販売：国別 (2017-2028)
    • ラテンアメリカの医薬品用造粒機の収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第11章 中東・アフリカ

  • 中東・アフリカの医薬品用造粒機 売上内訳：企業別
    • 中東・アフリカの医薬品用造粒機 売上：企業別 (2017-2022)
    • 中東・アフリカの医薬品用造粒機 収益：企業別 (2017-2022)
  • 中東・アフリカの医薬品用造粒機 市場規模：タイプ別
    • 中東・アフリカの医薬品用造粒機の販売：タイプ別 (2017-2028)
    • 中東・アフリカの医薬品用造粒機の収益：タイプ別 (2017-2028)
  • 中東・アフリカの医薬品用造粒機 市場規模：用途別
    • 中東・アフリカの医薬品用造粒機の販売：用途別 (2017-2028)
    • 中東・アフリカの医薬品用造粒機の収益：用途別 (2017-2028)
  • 中東・アフリカの医薬品用造粒機 市場規模：国別
    • 中東・アフリカの医薬品用造粒機の販売：国別 (2017-2028)
    • 中東・アフリカの医薬品用造粒機の収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア
    • U.A.E

第12章 企業プロファイル

  • LB Bohle
  • Three-Tec
  • LCI Corporation
  • Manes Macchine
  • IMA Sustain Ability
  • Alexanderwerk
  • Diosna
  • GEA Group
  • Frewitt

第13章 バリューチェーンと販売チャネルの分析

  • 医薬品用造粒機 バリューチェーンの分析
  • 医薬品用造粒機 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 医薬品用造粒機 生産形態とプロセス
  • 医薬品用造粒機 販売およびマーケティング
    • 医薬品用造粒機 販売チャネル
    • 医薬品用造粒機 卸業者
  • 医薬品用造粒機 顧客

第14章 主な調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Granulator for Pharmaceutical Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Dry Granulator
  • Table 3. Major Manufacturers of Wet Granulator
  • Table 4. Global Granulator for Pharmaceutical Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 5. Global Granulator for Pharmaceutical Production by Region: 2017 VS 2021 VS 2028 (K Units)
  • Table 6. Global Granulator for Pharmaceutical Production by Region (2017-2022) & (K Units)
  • Table 7. Global Granulator for Pharmaceutical Production Market Share by Region (2017-2022)
  • Table 8. Global Granulator for Pharmaceutical Production by Region (2023-2028) & (K Units)
  • Table 9. Global Granulator for Pharmaceutical Production Market Share by Region (2023-2028)
  • Table 10. Granulator for Pharmaceutical Market Trends
  • Table 11. Granulator for Pharmaceutical Market Drivers
  • Table 12. Granulator for Pharmaceutical Market Challenges
  • Table 13. Granulator for Pharmaceutical Market Restraints
  • Table 14. Global Granulator for Pharmaceutical Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 15. Global Granulator for Pharmaceutical Sales by Region (2017-2022) & (K Units)
  • Table 16. Global Granulator for Pharmaceutical Sales Market Share by Region (2017-2022)
  • Table 17. Global Granulator for Pharmaceutical Sales by Region (2023-2028) & (K Units)
  • Table 18. Global Granulator for Pharmaceutical Sales Market Share by Region (2023-2028)
  • Table 19. Global Granulator for Pharmaceutical Revenue by Region (2017-2022) & (US$ Million)
  • Table 20. Global Granulator for Pharmaceutical Revenue Market Share by Region (2017-2022)
  • Table 21. Global Granulator for Pharmaceutical Revenue by Region (2023-2028) & (US$ Million)
  • Table 22. Global Granulator for Pharmaceutical Revenue Market Share by Region (2023-2028)
  • Table 23. Global Granulator for Pharmaceutical Production Capacity by Manufacturers (2017-2022) & (K Units)
  • Table 24. Global Granulator for Pharmaceutical Capacity Market Share by Manufacturers (2017-2022)
  • Table 25. Global Granulator for Pharmaceutical Production by Manufacturers (2017-2022) & (K Units)
  • Table 26. Global Granulator for Pharmaceutical Production Market Share by Manufacturers (2017-2022)
  • Table 27. Global Granulator for Pharmaceutical Sales by Manufacturers (2017-2022) & (K Units)
  • Table 28. Global Granulator for Pharmaceutical Sales Share by Manufacturers (2017-2022)
  • Table 29. Global Granulator for Pharmaceutical Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 30. Global Granulator for Pharmaceutical Revenue Share by Manufacturers (2017-2022)
  • Table 31. Granulator for Pharmaceutical Price by Manufacturers 2017-2022 (USD/Unit)
  • Table 32. Global Granulator for Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 33. Global Granulator for Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granulator for Pharmaceutical as of 2021)
  • Table 34. Granulator for Pharmaceutical Manufacturing Base Distribution and Headquarters
  • Table 35. Manufacturers Granulator for Pharmaceutical Product Offered
  • Table 36. Date of Key Manufacturers Enter into Granulator for Pharmaceutical Market
  • Table 37. Mergers & Acquisitions, Expansion Plans
  • Table 38. Global Granulator for Pharmaceutical Sales by Type (2017-2022) & (K Units)
  • Table 39. Global Granulator for Pharmaceutical Sales by Type (2023-2028) & (K Units)
  • Table 40. Global Granulator for Pharmaceutical Sales Share by Type (2017-2022)
  • Table 41. Global Granulator for Pharmaceutical Sales Share by Type (2023-2028)
  • Table 42. Global Granulator for Pharmaceutical Revenue by Type (2017-2022) & (US$ Million)
  • Table 43. Global Granulator for Pharmaceutical Revenue by Type (2023-2028) & (US$ Million)
  • Table 44. Global Granulator for Pharmaceutical Revenue Share by Type (2017-2022)
  • Table 45. Global Granulator for Pharmaceutical Revenue Share by Type (2023-2028)
  • Table 46. Granulator for Pharmaceutical Price by Type (2017-2022) & (USD/Unit)
  • Table 47. Global Granulator for Pharmaceutical Price Forecast by Type (2023-2028) & (USD/Unit)
  • Table 48. Global Granulator for Pharmaceutical Sales by Application (2017-2022) & (K Units)
  • Table 49. Global Granulator for Pharmaceutical Sales by Application (2023-2028) & (K Units)
  • Table 50. Global Granulator for Pharmaceutical Sales Share by Application (2017-2022)
  • Table 51. Global Granulator for Pharmaceutical Sales Share by Application (2023-2028)
  • Table 52. Global Granulator for Pharmaceutical Revenue by Application (2017-2022) & (US$ Million)
  • Table 53. Global Granulator for Pharmaceutical Revenue by Application (2023-2028) & (US$ Million)
  • Table 54. Global Granulator for Pharmaceutical Revenue Share by Application (2017-2022)
  • Table 55. Global Granulator for Pharmaceutical Revenue Share by Application (2023-2028)
  • Table 56. Granulator for Pharmaceutical Price by Application (2017-2022) & (USD/Unit)
  • Table 57. Global Granulator for Pharmaceutical Price Forecast by Application (2023-2028) & (USD/Unit)
  • Table 58. North America Granulator for Pharmaceutical Sales by Company (2017-2022) & (K Units)
  • Table 59. North America Granulator for Pharmaceutical Sales Market Share by Company (2017-2022)
  • Table 60. North America Granulator for Pharmaceutical Revenue by Company (2017-2022) & (US$ Million)
  • Table 61. North America Granulator for Pharmaceutical Revenue Market Share by Company (2017-2022)
  • Table 62. North America Granulator for Pharmaceutical Sales by Type (2017-2022) & (K Units)
  • Table 63. North America Granulator for Pharmaceutical Sales by Type (2023-2028) & (K Units)
  • Table 64. North America Granulator for Pharmaceutical Revenue by Type (2017-2022) & (US$ Million)
  • Table 65. North America Granulator for Pharmaceutical Revenue by Type (2023-2028) & (US$ Million)
  • Table 66. North America Granulator for Pharmaceutical Sales by Application (2017-2022) & (K Units)
  • Table 67. North America Granulator for Pharmaceutical Sales by Application (2023-2028) & (K Units)
  • Table 68. North America Granulator for Pharmaceutical Revenue by Application (2017-2022) & (US$ Million)
  • Table 69. North America Granulator for Pharmaceutical Revenue by Application (2023-2028) & (US$ Million)
  • Table 70. North America Granulator for Pharmaceutical Sales by Country (2017-2022) & (K Units)
  • Table 71. North America Granulator for Pharmaceutical Sales by Country (2023-2028) & (K Units)
  • Table 72. North America Granulator for Pharmaceutical Revenue by Country (2017-2022) & (US$ Million)
  • Table 73. North America Granulator for Pharmaceutical Revenue by Country (2023-2028) & (US$ Million)
  • Table 74. Europe Granulator for Pharmaceutical Sales by Company (2017-2022) & (K Units)
  • Table 75. Europe Granulator for Pharmaceutical Sales Market Share by Company (2017-2022)
  • Table 76. Europe Granulator for Pharmaceutical Revenue by Company (2017-2022) & (US$ Million)
  • Table 77. Europe Granulator for Pharmaceutical Revenue Market Share by Company (2017-2022)
  • Table 78. Europe Granulator for Pharmaceutical Sales by Type (2017-2022) & (K Units)
  • Table 79. Europe Granulator for Pharmaceutical Sales by Type (2023-2028) & (K Units)
  • Table 80. Europe Granulator for Pharmaceutical Revenue by Type (2017-2022) & (US$ Million)
  • Table 81. Europe Granulator for Pharmaceutical Revenue by Type (2023-2028) & (US$ Million)
  • Table 82. Europe Granulator for Pharmaceutical Sales by Application (2017-2022) & (K Units)
  • Table 83. Europe Granulator for Pharmaceutical Sales by Application (2023-2028) & (K Units)
  • Table 84. Europe Granulator for Pharmaceutical Revenue by Application (2017-2022) & (US$ Million)
  • Table 85. Europe Granulator for Pharmaceutical Revenue by Application (2023-2028) & (US$ Million)
  • Table 86. Europe Granulator for Pharmaceutical Sales by Country (2017-2022) & (K Units)
  • Table 87. Europe Granulator for Pharmaceutical Sales by Country (2023-2028) & (K Units)
  • Table 88. Europe Granulator for Pharmaceutical Revenue by Country (2017-2022) & (US$ Million)
  • Table 89. Europe Granulator for Pharmaceutical Revenue by Country (2023-2028) & (US$ Million)
  • Table 90. Asia Pacific Granulator for Pharmaceutical Sales by Company (2017-2022) & (K Units)
  • Table 91. Asia Pacific Granulator for Pharmaceutical Sales Market Share by Company (2017-2022)
  • Table 92. Asia Pacific Granulator for Pharmaceutical Revenue by Company (2017-2022) & (US$ Million)
  • Table 93. Asia Pacific Granulator for Pharmaceutical Revenue Market Share by Company (2017-2022)
  • Table 94. Asia Pacific Granulator for Pharmaceutical Sales by Type (2017-2022) & (K Units)
  • Table 95. Asia Pacific Granulator for Pharmaceutical Sales by Type (2023-2028) & (K Units)
  • Table 96. Asia Pacific Granulator for Pharmaceutical Revenue by Type (2017-2022) & (US$ Million)
  • Table 97. Asia Pacific Granulator for Pharmaceutical Revenue by Type (2023-2028) & (US$ Million)
  • Table 98. Asia Pacific Granulator for Pharmaceutical Sales by Application (2017-2022) & (K Units)
  • Table 99. Asia Pacific Granulator for Pharmaceutical Sales by Application (2023-2028) & (K Units)
  • Table 100. Asia Pacific Granulator for Pharmaceutical Revenue by Application (2017-2022) & (US$ Million)
  • Table 101. Asia Pacific Granulator for Pharmaceutical Revenue by Application (2023-2028) & (US$ Million)
  • Table 102. Asia Pacific Granulator for Pharmaceutical Sales by Region (2017-2022) & (K Units)
  • Table 103. Asia Pacific Granulator for Pharmaceutical Sales by Region (2023-2028) & (K Units)
  • Table 104. Asia Pacific Granulator for Pharmaceutical Revenue by Region (2017-2022) & (US$ Million)
  • Table 105. Asia Pacific Granulator for Pharmaceutical Revenue by Region (2023-2028) & (US$ Million)
  • Table 106. Latin America Granulator for Pharmaceutical Sales by Company (2017-2022) & (K Units)
  • Table 107. Latin America Granulator for Pharmaceutical Sales Market Share by Company (2017-2022)
  • Table 108. Latin America Granulator for Pharmaceutical Revenue by Company (2017-2022) & (US$ Million)
  • Table 109. Latin America Granulator for Pharmaceutical Revenue Market Share by Company (2017-2022)
  • Table 110. Latin America Granulator for Pharmaceutical Sales by Type (2017-2022) & (K Units)
  • Table 111. Latin America Granulator for Pharmaceutical Sales by Type (2023-2028) & (K Units)
  • Table 112. Latin America Granulator for Pharmaceutical Revenue by Type (2017-2022) & (US$ Million)
  • Table 113. Latin America Granulator for Pharmaceutical Revenue by Type (2023-2028) & (US$ Million)
  • Table 114. Latin America Granulator for Pharmaceutical Sales by Application (2017-2022) & (K Units)
  • Table 115. Latin America Granulator for Pharmaceutical Sales by Application (2023-2028) & (K Units)
  • Table 116. Latin America Granulator for Pharmaceutical Revenue by Application (2017-2022) & (US$ Million)
  • Table 117. Latin America Granulator for Pharmaceutical Revenue by Application (2023-2028) & (US$ Million)
  • Table 118. Latin America Granulator for Pharmaceutical Sales by Country (2017-2022) & (K Units)
  • Table 119. Latin America Granulator for Pharmaceutical Sales by Country (2023-2028) & (K Units)
  • Table 120. Latin America Granulator for Pharmaceutical Revenue by Country (2017-2022) & (US$ Million)
  • Table 121. Latin America Granulator for Pharmaceutical Revenue by Country (2023-2028) & (US$ Million)
  • Table 122. Middle East and Africa Granulator for Pharmaceutical Sales by Company (2017-2022) & (K Units)
  • Table 123. Middle East and Africa Granulator for Pharmaceutical Sales Market Share by Company (2017-2022)
  • Table 124. Middle East and Africa Granulator for Pharmaceutical Revenue by Company (2017-2022) & (US$ Million)
  • Table 125. Middle East and Africa Granulator for Pharmaceutical Revenue Market Share by Company (2017-2022)
  • Table 126. Middle East and Africa Granulator for Pharmaceutical Sales by Type (2017-2022) & (K Units)
  • Table 127. Middle East and Africa Granulator for Pharmaceutical Sales by Type (2023-2028) & (K Units)
  • Table 128. Middle East and Africa Granulator for Pharmaceutical Revenue by Type (2017-2022) & (US$ Million)
  • Table 129. Middle East and Africa Granulator for Pharmaceutical Revenue by Type (2023-2028) & (US$ Million)
  • Table 130. Middle East and Africa Granulator for Pharmaceutical Sales by Application (2017-2022) & (K Units)
  • Table 131. Middle East and Africa Granulator for Pharmaceutical Sales by Application (2023-2028) & (K Units)
  • Table 132. Middle East and Africa Granulator for Pharmaceutical Revenue by Application (2017-2022) & (US$ Million)
  • Table 133. Middle East and Africa Granulator for Pharmaceutical Revenue by Application (2023-2028) & (US$ Million)
  • Table 134. Middle East and Africa Granulator for Pharmaceutical Sales by Country (2017-2022) & (K Units)
  • Table 135. Middle East and Africa Granulator for Pharmaceutical Sales by Country (2023-2028) & (K Units)
  • Table 136. Middle East and Africa Granulator for Pharmaceutical Revenue by Country (2017-2022) & (US$ Million)
  • Table 137. Middle East and Africa Granulator for Pharmaceutical Revenue by Country (2023-2028) & (US$ Million)
  • Table 138. LB Bohle Corporation Information
  • Table 139. LB Bohle Description and Overview
  • Table 140. LB Bohle Granulator for Pharmaceutical Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) & (USD/Unit) and Gross Margin (2017-2022)
  • Table 141. LB Bohle Granulator for Pharmaceutical Products and Services
  • Table 142. LB Bohle Granulator for Pharmaceutical SWOT Analysis
  • Table 143. LB Bohle Recent Development
  • Table 144. Three-Tec Corporation Information
  • Table 145. Three-Tec Description and Overview
  • Table 146. Three-Tec Granulator for Pharmaceutical Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) & (USD/Unit) and Gross Margin (2017-2022)
  • Table 147. Three-Tec Granulator for Pharmaceutical Products and Services
  • Table 148. Three-Tec Granulator for Pharmaceutical SWOT Analysis
  • Table 149. Three-Tec Recent Development
  • Table 150. LCI Corporation Corporation Information
  • Table 151. LCI Corporation Description and Overview
  • Table 152. LCI Corporation Granulator for Pharmaceutical Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) & (USD/Unit) and Gross Margin (2017-2022)
  • Table 153. LCI Corporation Granulator for Pharmaceutical Products and Services
  • Table 154. LCI Corporation Granulator for Pharmaceutical SWOT Analysis
  • Table 155. LCI Corporation Recent Development
  • Table 156. Manes Macchine Corporation Information
  • Table 157. Manes Macchine Description and Overview
  • Table 158. Manes Macchine Granulator for Pharmaceutical Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) & (USD/Unit) and Gross Margin (2017-2022)
  • Table 159. Manes Macchine Granulator for Pharmaceutical Products and Services
  • Table 160. Manes Macchine Granulator for Pharmaceutical SWOT Analysis
  • Table 161. Manes Macchine Recent Development
  • Table 162. IMA Sustain Ability Corporation Information
  • Table 163. IMA Sustain Ability Description and Overview
  • Table 164. IMA Sustain Ability Granulator for Pharmaceutical Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) & (USD/Unit) and Gross Margin (2017-2022)
  • Table 165. IMA Sustain Ability Granulator for Pharmaceutical Products and Services
  • Table 166. IMA Sustain Ability Granulator for Pharmaceutical SWOT Analysis
  • Table 167. IMA Sustain Ability Recent Development
  • Table 168. Alexanderwerk Corporation Information
  • Table 169. Alexanderwerk Description and Overview
  • Table 170. Alexanderwerk Granulator for Pharmaceutical Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) & (USD/Unit) and Gross Margin (2017-2022)
  • Table 171. Alexanderwerk Granulator for Pharmaceutical Products and Services
  • Table 172. Alexanderwerk Granulator for Pharmaceutical SWOT Analysis
  • Table 173. Alexanderwerk Recent Development
  • Table 174. Diosna Corporation Information
  • Table 175. Diosna Description and Overview
  • Table 176. Diosna Granulator for Pharmaceutical Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) & (USD/Unit) and Gross Margin (2017-2022)
  • Table 177. Diosna Granulator for Pharmaceutical Products and Services
  • Table 178. Diosna Granulator for Pharmaceutical SWOT Analysis
  • Table 179. Diosna Recent Development
  • Table 180. GEA Group Corporation Information
  • Table 181. GEA Group Description and Overview
  • Table 182. GEA Group Granulator for Pharmaceutical Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) & (USD/Unit) and Gross Margin (2017-2022)
  • Table 183. GEA Group Granulator for Pharmaceutical Products and Services
  • Table 184. GEA Group Granulator for Pharmaceutical SWOT Analysis
  • Table 185. GEA Group Recent Development
  • Table 186. Frewitt Corporation Information
  • Table 187. Frewitt Description and Overview
  • Table 188. Frewitt Granulator for Pharmaceutical Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) & (USD/Unit) and Gross Margin (2017-2022)
  • Table 189. Frewitt Granulator for Pharmaceutical Products and Services
  • Table 190. Frewitt Granulator for Pharmaceutical SWOT Analysis
  • Table 191. Frewitt Recent Development
  • Table 192. Key Raw Materials Lists
  • Table 193. Raw Materials Key Suppliers Lists
  • Table 194. Granulator for Pharmaceutical Distributors List
  • Table 195. Granulator for Pharmaceutical Customers List
  • Table 196. Research Programs/Design for This Report
  • Table 197. Key Data Information from Secondary Sources
  • Table 198. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Granulator for Pharmaceutical Product Picture
  • Figure 2. Global Granulator for Pharmaceutical Market Share by Type in 2021 & 2028
  • Figure 3. Dry Granulator Product Picture
  • Figure 4. Wet Granulator Product Picture
  • Figure 5. Global Granulator for Pharmaceutical Market Share by Application in 2021 & 2028
  • Figure 6. Pharmaceutical Company
  • Figure 7. Other
  • Figure 8. Granulator for Pharmaceutical Report Years Considered
  • Figure 9. Global Granulator for Pharmaceutical Capacity, Production and Utilization (2017-2028) & (K Units)
  • Figure 10. Global Granulator for Pharmaceutical Production Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 11. Global Granulator for Pharmaceutical Production Market Share by Region (2017-2022)
  • Figure 12. Global Granulator for Pharmaceutical Production Market Share by Region (2023-2028)
  • Figure 13. Granulator for Pharmaceutical Production Growth Rate in North America (2017-2028) & (K Units)
  • Figure 14. Granulator for Pharmaceutical Production Growth Rate in Europe (2017-2028) & (K Units)
  • Figure 15. Granulator for Pharmaceutical Production Growth Rate in Japan (2017-2028) & (K Units)
  • Figure 16. Granulator for Pharmaceutical Production Growth Rate in China (2017-2028) & (K Units)
  • Figure 17. Granulator for Pharmaceutical Production Growth Rate in South Korea (2017-2028) & (K Units)
  • Figure 18. Granulator for Pharmaceutical Production Growth Rate in India (2017-2028) & (K Units)
  • Figure 19. Global Granulator for Pharmaceutical Sales 2017-2028 (K Units)
  • Figure 20. Global Granulator for Pharmaceutical Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 21. Global Granulator for Pharmaceutical Revenue 2017-2028 (US$ Million)
  • Figure 22. Global Granulator for Pharmaceutical Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 23. Global Granulator for Pharmaceutical Sales Market Share by Region (2017-2022)
  • Figure 24. Global Granulator for Pharmaceutical Sales Market Share by Region (2023-2028)
  • Figure 25. North America Granulator for Pharmaceutical Sales YoY (2017-2028) & (K Units)
  • Figure 26. North America Granulator for Pharmaceutical Revenue YoY (2017-2028) & (US$ Million)
  • Figure 27. Europe Granulator for Pharmaceutical Sales YoY (2017-2028) & (K Units)
  • Figure 28. Europe Granulator for Pharmaceutical Revenue YoY (2017-2028) & (US$ Million)
  • Figure 29. Asia-Pacific Granulator for Pharmaceutical Sales YoY (2017-2028) & (K Units)
  • Figure 30. Asia-Pacific Granulator for Pharmaceutical Revenue YoY (2017-2028) & (US$ Million)
  • Figure 31. Latin America Granulator for Pharmaceutical Sales YoY (2017-2028) & (K Units)
  • Figure 32. Latin America Granulator for Pharmaceutical Revenue YoY (2017-2028) & (US$ Million)
  • Figure 33. Middle East & Africa Granulator for Pharmaceutical Sales YoY (2017-2028) & (K Units)
  • Figure 34. Middle East & Africa Granulator for Pharmaceutical Revenue YoY (2017-2028) & (US$ Million)
  • Figure 35. The Top 10 and Top 5 Players Market Share by Granulator for Pharmaceutical Sales in 2021
  • Figure 36. The Top 10 and Top 5 Players Market Share by Granulator for Pharmaceutical Revenue in 2021
  • Figure 37. Granulator for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 38. Global Granulator for Pharmaceutical Sales Market Share by Type (2017-2028)
  • Figure 39. Global Granulator for Pharmaceutical Revenue Market Share by Type (2017-2028)
  • Figure 40. Global Granulator for Pharmaceutical Sales Market Share by Application (2017-2028)
  • Figure 41. Global Granulator for Pharmaceutical Revenue Market Share by Application (2017-2028)
  • Figure 42. North America Granulator for Pharmaceutical Sales Market Share by Type (2017-2028)
  • Figure 43. North America Granulator for Pharmaceutical Revenue Market Share by Type (2017-2028)
  • Figure 44. North America Granulator for Pharmaceutical Sales Market Share by Application (2017-2028)
  • Figure 45. North America Granulator for Pharmaceutical Revenue Market Share by Application (2017-2028)
  • Figure 46. North America Granulator for Pharmaceutical Sales Share by Country (2017-2028)
  • Figure 47. North America Granulator for Pharmaceutical Revenue Share by Country (2017-2028)
  • Figure 48. U.S. Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 49. Canada Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 50. Europe Granulator for Pharmaceutical Sales Market Share by Type (2017-2028)
  • Figure 51. Europe Granulator for Pharmaceutical Revenue Market Share by Type (2017-2028)
  • Figure 52. Europe Granulator for Pharmaceutical Sales Market Share by Application (2017-2028)
  • Figure 53. Europe Granulator for Pharmaceutical Revenue Market Share by Application (2017-2028)
  • Figure 54. Europe Granulator for Pharmaceutical Sales Share by Country (2017-2028)
  • Figure 55. Europe Granulator for Pharmaceutical Revenue Share by Country (2017-2028)
  • Figure 56. Germany Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 57. France Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 58. U.K. Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 59. Italy Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 60. Russia Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 61. Asia-Pacific Granulator for Pharmaceutical Sales Market Share by Type (2017-2028)
  • Figure 62. Asia-Pacific Granulator for Pharmaceutical Revenue Market Share by Type (2017-2028)
  • Figure 63. Asia-Pacific Granulator for Pharmaceutical Sales Market Share by Application (2017-2028)
  • Figure 64. Asia-Pacific Granulator for Pharmaceutical Revenue Market Share by Application (2017-2028)
  • Figure 65. Asia-Pacific Granulator for Pharmaceutical Sales Share by Region (2017-2028)
  • Figure 66. Asia-Pacific Granulator for Pharmaceutical Revenue Share by Region (2017-2028)
  • Figure 67. China Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 68. Japan Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 69. South Korea Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 70. India Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 71. Australia Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 72. Taiwan Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 73. Indonesia Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 74. Thailand Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 75. Malaysia Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 76. Philippines Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 77. Latin America Granulator for Pharmaceutical Sales Market Share by Type (2017-2028)
  • Figure 78. Latin America Granulator for Pharmaceutical Revenue Market Share by Type (2017-2028)
  • Figure 79. Latin America Granulator for Pharmaceutical Sales Market Share by Application (2017-2028)
  • Figure 80. Latin America Granulator for Pharmaceutical Revenue Market Share by Application (2017-2028)
  • Figure 81. Latin America Granulator for Pharmaceutical Sales Share by Country (2017-2028)
  • Figure 82. Latin America Granulator for Pharmaceutical Revenue Share by Country (2017-2028)
  • Figure 83. Mexico Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 84. Brazil Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 85. Argentina Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 86. Middle East & Africa Granulator for Pharmaceutical Sales Market Share by Type (2017-2028)
  • Figure 87. Middle East & Africa Granulator for Pharmaceutical Revenue Market Share by Type (2017-2028)
  • Figure 88. Middle East & Africa Granulator for Pharmaceutical Sales Market Share by Application (2017-2028)
  • Figure 89. Middle East & Africa Granulator for Pharmaceutical Revenue Market Share by Application (2017-2028)
  • Figure 90. Middle East & Africa Granulator for Pharmaceutical Sales Share by Country (2017-2028)
  • Figure 91. Middle East & Africa Granulator for Pharmaceutical Revenue Share by Country (2017-2028)
  • Figure 92. Turkey Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 93. Saudi Arabia Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 94. U.A.E Granulator for Pharmaceutical Revenue (2017-2028) & (US$ Million)
  • Figure 95. Granulator for Pharmaceutical Value Chain
  • Figure 96. Granulator for Pharmaceutical Production Process
  • Figure 97. Channels of Distribution
  • Figure 98. Distributors Profiles
  • Figure 99. Bottom-up and Top-down Approaches for This Report
  • Figure 100. Data Triangulation
  • Figure 101. Key Executives Interviewed
目次

This research report focuses on the Granulator for Pharmaceutical Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Granulator for Pharmaceutical Research Scope
  • 1.2 Market Segment by Type
    • 1.2.1 Global Granulator for Pharmaceutical Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Dry Granulator
    • 1.2.3 Wet Granulator
  • 1.3 Market Segment by Application
    • 1.3.1 Global Granulator for Pharmaceutical Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Pharmaceutical Company
    • 1.3.3 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Market Production

  • 2.1 Global Granulator for Pharmaceutical Production Capacity (2017-2028)
  • 2.2 Global Granulator for Pharmaceutical Production by Region: 2017 VS 2021 VS 2028
  • 2.3 Global Granulator for Pharmaceutical Production by Region
    • 2.3.1 Global Granulator for Pharmaceutical Historic Production by Region (2017-2022)
    • 2.3.2 Global Granulator for Pharmaceutical Forecasted Production by Region (2023-2028)
    • 2.3.3 North America
    • 2.3.4 Europe
    • 2.3.5 Japan
    • 2.3.6 China
    • 2.3.7 South Korea
    • 2.3.8 India
  • 2.4 Market Dynamics
    • 2.4.1 Granulator for Pharmaceutical Industry Trends
    • 2.4.2 Granulator for Pharmaceutical Market Drivers
    • 2.4.3 Granulator for Pharmaceutical Market Challenges
    • 2.4.4 Granulator for Pharmaceutical Market Restraints

3 Global Granulator for Pharmaceutical Sales

  • 3.1 Global Granulator for Pharmaceutical Sales Estimates and Forecasts 2017-2028
  • 3.2 Global Granulator for Pharmaceutical Revenue Estimates and Forecasts 2017-2028
  • 3.3 Global Granulator for Pharmaceutical Revenue by Region: 2017 VS 2021 VS 2028
  • 3.4 Global Top Granulator for Pharmaceutical Regions by Sales
    • 3.4.1 Global Top Granulator for Pharmaceutical Regions by Sales (2017-2022)
    • 3.4.2 Global Top Granulator for Pharmaceutical Regions by Sales (2023-2028)
  • 3.5 Global Top Granulator for Pharmaceutical Regions by Revenue
    • 3.5.1 Global Top Granulator for Pharmaceutical Regions by Revenue (2017-2022)
    • 3.5.2 Global Top Granulator for Pharmaceutical Regions by Revenue (2023-2028)
    • 3.5.3 North America
    • 3.5.4 Europe
    • 3.5.5 Asia-Pacific
    • 3.5.6 Latin America
    • 3.5.7 Middle East & Africa

4 Competition by Manufacturers

  • 4.1 Global Granulator for Pharmaceutical Production Capacity by Manufacturers
  • 4.2 Global Granulator for Pharmaceutical Sales by Manufacturers
    • 4.2.1 Global Top Granulator for Pharmaceutical Manufacturers by Sales (2017-2022)
    • 4.2.2 Global Top Granulator for Pharmaceutical Manufacturers Market Share by Sales (2017-2022)
    • 4.2.3 Global Top 10 and Top 5 Companies by Granulator for Pharmaceutical Sales in 2021
  • 4.3 Global Granulator for Pharmaceutical Revenue by Manufacturers
    • 4.3.1 Global Top Granulator for Pharmaceutical Manufacturers by Revenue (2017-2022)
    • 4.3.2 Global Top Granulator for Pharmaceutical Manufacturers Market Share by Revenue (2017-2022)
    • 4.3.3 Global Top 10 and Top 5 Companies by Granulator for Pharmaceutical Revenue in 2021
  • 4.4 Global Granulator for Pharmaceutical Sales Price by Manufacturers
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Granulator for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.5.3 Global Granulator for Pharmaceutical Manufacturers Geographical Distribution
  • 4.6 Mergers & Acquisitions, Expansion Plans

5 Estimates and Forecasts by Type

  • 5.1 Global Granulator for Pharmaceutical Sales by Type
    • 5.1.1 Global Granulator for Pharmaceutical Historical Sales by Type (2017-2022)
    • 5.1.2 Global Granulator for Pharmaceutical Forecasted Sales by Type (2023-2028)
    • 5.1.3 Global Granulator for Pharmaceutical Sales Market Share by Type (2017-2028)
  • 5.2 Global Granulator for Pharmaceutical Revenue by Type
    • 5.2.1 Global Granulator for Pharmaceutical Historical Revenue by Type (2017-2022)
    • 5.2.2 Global Granulator for Pharmaceutical Forecasted Revenue by Type (2023-2028)
    • 5.2.3 Global Granulator for Pharmaceutical Revenue Market Share by Type (2017-2028)
  • 5.3 Global Granulator for Pharmaceutical Price by Type
    • 5.3.1 Global Granulator for Pharmaceutical Price by Type (2017-2022)
    • 5.3.2 Global Granulator for Pharmaceutical Price Forecast by Type (2023-2028)

6 Market Size by Application

  • 6.1 Global Granulator for Pharmaceutical Sales by Application
    • 6.1.1 Global Granulator for Pharmaceutical Historical Sales by Application (2017-2022)
    • 6.1.2 Global Granulator for Pharmaceutical Forecasted Sales by Application (2023-2028)
    • 6.1.3 Global Granulator for Pharmaceutical Sales Market Share by Application (2017-2028)
  • 6.2 Global Granulator for Pharmaceutical Revenue by Application
    • 6.2.1 Global Granulator for Pharmaceutical Historical Revenue by Application (2017-2022)
    • 6.2.2 Global Granulator for Pharmaceutical Forecasted Revenue by Application (2023-2028)
    • 6.2.3 Global Granulator for Pharmaceutical Revenue Market Share by Application (2017-2028)
  • 6.3 Global Granulator for Pharmaceutical Price by Application
    • 6.3.1 Global Granulator for Pharmaceutical Price by Application (2017-2022)
    • 6.3.2 Global Granulator for Pharmaceutical Price Forecast by Application (2023-2028)

7 North America

  • 7.1 North America Granulator for Pharmaceutical Sales Breakdown by Company
    • 7.1.1 North America Granulator for Pharmaceutical Sales by Company (2017-2022)
    • 7.1.2 North America Granulator for Pharmaceutical Revenue by Company (2017-2022)
  • 7.2 North America Granulator for Pharmaceutical Market Size by Type
    • 7.2.1 North America Granulator for Pharmaceutical Sales by Type (2017-2028)
    • 7.2.2 North America Granulator for Pharmaceutical Revenue by Type (2017-2028)
  • 7.3 North America Granulator for Pharmaceutical Market Size by Application
    • 7.3.1 North America Granulator for Pharmaceutical Sales by Application (2017-2028)
    • 7.3.2 North America Granulator for Pharmaceutical Revenue by Application (2017-2028)
  • 7.4 North America Granulator for Pharmaceutical Market Size by Country
    • 7.4.1 North America Granulator for Pharmaceutical Sales by Country (2017-2028)
    • 7.4.2 North America Granulator for Pharmaceutical Revenue by Country (2017-2028)
    • 7.4.3 U.S.
    • 7.4.4 Canada

8 Europe

  • 8.1 Europe Granulator for Pharmaceutical Sales Breakdown by Company
    • 8.1.1 Europe Granulator for Pharmaceutical Sales by Company (2017-2022)
    • 8.1.2 Europe Granulator for Pharmaceutical Revenue by Company (2017-2022)
  • 8.2 Europe Granulator for Pharmaceutical Market Size by Type
    • 8.2.1 Europe Granulator for Pharmaceutical Sales by Type (2017-2028)
    • 8.2.2 Europe Granulator for Pharmaceutical Revenue by Type (2017-2028)
  • 8.3 Europe Granulator for Pharmaceutical Market Size by Application
    • 8.3.1 Europe Granulator for Pharmaceutical Sales by Application (2017-2028)
    • 8.3.2 Europe Granulator for Pharmaceutical Revenue by Application (2017-2028)
  • 8.4 Europe Granulator for Pharmaceutical Market Size by Country
    • 8.4.1 Europe Granulator for Pharmaceutical Sales by Country (2017-2028)
    • 8.4.2 Europe Granulator for Pharmaceutical Revenue by Country (2017-2028)
    • 8.4.3 Germany
    • 8.4.4 France
    • 8.4.5 U.K.
    • 8.4.6 Italy
    • 8.4.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Granulator for Pharmaceutical Sales Breakdown by Company
    • 9.1.1 Asia Pacific Granulator for Pharmaceutical Sales by Company (2017-2022)
    • 9.1.2 Asia Pacific Granulator for Pharmaceutical Revenue by Company (2017-2022)
  • 9.2 Asia Pacific Granulator for Pharmaceutical Market Size by Type
    • 9.2.1 Asia Pacific Granulator for Pharmaceutical Sales by Type (2017-2028)
    • 9.2.2 Asia Pacific Granulator for Pharmaceutical Revenue by Type (2017-2028)
  • 9.3 Asia Pacific Granulator for Pharmaceutical Market Size by Application
    • 9.3.1 Asia Pacific Granulator for Pharmaceutical Sales by Application (2017-2028)
    • 9.3.2 Asia Pacific Granulator for Pharmaceutical Revenue by Application (2017-2028)
  • 9.4 Asia Pacific Granulator for Pharmaceutical Market Size by Region
    • 9.4.1 Asia Pacific Granulator for Pharmaceutical Sales by Region (2017-2028)
    • 9.4.2 Asia Pacific Granulator for Pharmaceutical Revenue by Region (2017-2028)
    • 9.4.3 China
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 India
    • 9.4.7 Australia
    • 9.4.8 Taiwan
    • 9.4.9 Indonesia
    • 9.4.10 Thailand
    • 9.4.11 Malaysia
    • 9.4.12 Philippines

10 Latin America

  • 10.1 Latin America Granulator for Pharmaceutical Sales Breakdown by Company
    • 10.1.1 Latin America Granulator for Pharmaceutical Sales by Company (2017-2022)
    • 10.1.2 Latin America Granulator for Pharmaceutical Revenue by Company (2017-2022)
  • 10.2 Latin America Granulator for Pharmaceutical Market Size by Type
    • 10.2.1 Latin America Granulator for Pharmaceutical Sales by Type (2017-2028)
    • 10.2.2 Latin America Granulator for Pharmaceutical Revenue by Type (2017-2028)
  • 10.3 Latin America Granulator for Pharmaceutical Market Size by Application
    • 10.3.1 Latin America Granulator for Pharmaceutical Sales by Application (2017-2028)
    • 10.3.2 Latin America Granulator for Pharmaceutical Revenue by Application (2017-2028)
  • 10.4 Latin America Granulator for Pharmaceutical Market Size by Country
    • 10.4.1 Latin America Granulator for Pharmaceutical Sales by Country (2017-2028)
    • 10.4.2 Latin America Granulator for Pharmaceutical Revenue by Country (2017-2028)
    • 10.4.3 Mexico
    • 10.4.4 Brazil
    • 10.4.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Granulator for Pharmaceutical Sales Breakdown by Company
    • 11.1.1 Middle East and Africa Granulator for Pharmaceutical Sales by Company (2017-2022)
    • 11.1.2 Middle East and Africa Granulator for Pharmaceutical Revenue by Company (2017-2022)
  • 11.2 Middle East and Africa Granulator for Pharmaceutical Market Size by Type
    • 11.2.1 Middle East and Africa Granulator for Pharmaceutical Sales by Type (2017-2028)
    • 11.2.2 Middle East and Africa Granulator for Pharmaceutical Revenue by Type (2017-2028)
  • 11.3 Middle East and Africa Granulator for Pharmaceutical Market Size by Application
    • 11.3.1 Middle East and Africa Granulator for Pharmaceutical Sales by Application (2017-2028)
    • 11.3.2 Middle East and Africa Granulator for Pharmaceutical Revenue by Application (2017-2028)
  • 11.4 Middle East and Africa Granulator for Pharmaceutical Market Size by Country
    • 11.4.1 Middle East and Africa Granulator for Pharmaceutical Sales by Country (2017-2028)
    • 11.4.2 Middle East and Africa Granulator for Pharmaceutical Revenue by Country (2017-2028)
    • 11.4.3 Turkey
    • 11.4.4 Saudi Arabia
    • 11.4.5 U.A.E

12 Company Profiles

  • 12.1 LB Bohle
    • 12.1.1 LB Bohle Corporation Information
    • 12.1.2 LB Bohle Overview
    • 12.1.3 LB Bohle Granulator for Pharmaceutical Sales, Revenue, Price and Gross Margin (2017-2022)
    • 12.1.4 LB Bohle Granulator for Pharmaceutical Products and Services
    • 12.1.5 LB Bohle Granulator for Pharmaceutical SWOT Analysis
    • 12.1.6 LB Bohle Recent Developments
  • 12.2 Three-Tec
    • 12.2.1 Three-Tec Corporation Information
    • 12.2.2 Three-Tec Overview
    • 12.2.3 Three-Tec Granulator for Pharmaceutical Sales, Revenue, Price and Gross Margin (2017-2022)
    • 12.2.4 Three-Tec Granulator for Pharmaceutical Products and Services
    • 12.2.5 Three-Tec Granulator for Pharmaceutical SWOT Analysis
    • 12.2.6 Three-Tec Recent Developments
  • 12.3 LCI Corporation
    • 12.3.1 LCI Corporation Corporation Information
    • 12.3.2 LCI Corporation Overview
    • 12.3.3 LCI Corporation Granulator for Pharmaceutical Sales, Revenue, Price and Gross Margin (2017-2022)
    • 12.3.4 LCI Corporation Granulator for Pharmaceutical Products and Services
    • 12.3.5 LCI Corporation Granulator for Pharmaceutical SWOT Analysis
    • 12.3.6 LCI Corporation Recent Developments
  • 12.4 Manes Macchine
    • 12.4.1 Manes Macchine Corporation Information
    • 12.4.2 Manes Macchine Overview
    • 12.4.3 Manes Macchine Granulator for Pharmaceutical Sales, Revenue, Price and Gross Margin (2017-2022)
    • 12.4.4 Manes Macchine Granulator for Pharmaceutical Products and Services
    • 12.4.5 Manes Macchine Granulator for Pharmaceutical SWOT Analysis
    • 12.4.6 Manes Macchine Recent Developments
  • 12.5 IMA Sustain Ability
    • 12.5.1 IMA Sustain Ability Corporation Information
    • 12.5.2 IMA Sustain Ability Overview
    • 12.5.3 IMA Sustain Ability Granulator for Pharmaceutical Sales, Revenue, Price and Gross Margin (2017-2022)
    • 12.5.4 IMA Sustain Ability Granulator for Pharmaceutical Products and Services
    • 12.5.5 IMA Sustain Ability Granulator for Pharmaceutical SWOT Analysis
    • 12.5.6 IMA Sustain Ability Recent Developments
  • 12.6 Alexanderwerk
    • 12.6.1 Alexanderwerk Corporation Information
    • 12.6.2 Alexanderwerk Overview
    • 12.6.3 Alexanderwerk Granulator for Pharmaceutical Sales, Revenue, Price and Gross Margin (2017-2022)
    • 12.6.4 Alexanderwerk Granulator for Pharmaceutical Products and Services
    • 12.6.5 Alexanderwerk Granulator for Pharmaceutical SWOT Analysis
    • 12.6.6 Alexanderwerk Recent Developments
  • 12.7 Diosna
    • 12.7.1 Diosna Corporation Information
    • 12.7.2 Diosna Overview
    • 12.7.3 Diosna Granulator for Pharmaceutical Sales, Revenue, Price and Gross Margin (2017-2022)
    • 12.7.4 Diosna Granulator for Pharmaceutical Products and Services
    • 12.7.5 Diosna Granulator for Pharmaceutical SWOT Analysis
    • 12.7.6 Diosna Recent Developments
  • 12.8 GEA Group
    • 12.8.1 GEA Group Corporation Information
    • 12.8.2 GEA Group Overview
    • 12.8.3 GEA Group Granulator for Pharmaceutical Sales, Revenue, Price and Gross Margin (2017-2022)
    • 12.8.4 GEA Group Granulator for Pharmaceutical Products and Services
    • 12.8.5 GEA Group Granulator for Pharmaceutical SWOT Analysis
    • 12.8.6 GEA Group Recent Developments
  • 12.9 Frewitt
    • 12.9.1 Frewitt Corporation Information
    • 12.9.2 Frewitt Overview
    • 12.9.3 Frewitt Granulator for Pharmaceutical Sales, Revenue, Price and Gross Margin (2017-2022)
    • 12.9.4 Frewitt Granulator for Pharmaceutical Products and Services
    • 12.9.5 Frewitt Granulator for Pharmaceutical SWOT Analysis
    • 12.9.6 Frewitt Recent Developments

13 Value Chain and Sales Channels Analysis

  • 13.1 Granulator for Pharmaceutical Value Chain Analysis
  • 13.2 Granulator for Pharmaceutical Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Granulator for Pharmaceutical Production Mode & Process
  • 13.4 Granulator for Pharmaceutical Sales and Marketing
    • 13.4.1 Granulator for Pharmaceutical Sales Channels
    • 13.4.2 Granulator for Pharmaceutical Distributors
  • 13.5 Granulator for Pharmaceutical Customers

14 Key Findings

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer